SCHEMBL5837263

SCHEMBL5837263

CCN(CC)Cc1ccc(NC(C)=O)cc1O

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
POLB P06746 6/20 0.54
ALDH1A1 P00352 4/20 0.51
MEN1 O00255 3/20 0.51
KMT2A Q03164 3/20 0.51
THRB P10828 2/20 0.51
MAPT P10636 2/20 0.51
TDP1 Q9NUW8 2/20 0.51
KDM4E B2RXH2 1/20 0.51
APEX1 P27695 1/20 0.51
MAPK1 P28482 1/20 0.51
HTT P42858 1/20 0.51
RECQL P46063 1/20 0.51
CACNA1B Q00975 1/20 0.51
APBA1 Q02410 1/20 0.51
MCL1 Q07820 1/20 0.51
HKDC1 Q2TB90 1/20 0.51
L3MBTL1 Q9Y468 1/20 0.51
SMN1; SMN2 Q16637 3/20 0.49
PKM P14618 1/20 0.49
OPRK1 P41145 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15094312 0.89 POLB (0.63) POLBALDH1A1MEN1KMT2ATHRB
SCHEMBL30230771 0.89 POLB (0.63) POLBALDH1A1MEN1KMT2ATHRB
SCHEMBL10445580 0.85 POLB (0.48) POLBALDH1A1MEN1KMT2AMAPT
SCHEMBL29939067 0.84 POLB (0.53) POLBALDH1A1MEN1KMT2ATHRB
SCHEMBL9582949 0.84 POLB (0.53) POLBALDH1A1MEN1KMT2ATHRB
SCHEMBL9603796 0.84 POLB (0.47) POLBALDH1A1MEN1KMT2AMAPT
SCHEMBL2855498 0.84 POLB (0.63) POLBALDH1A1MEN1KMT2AMAPT
SCHEMBL15279552 0.81 POLB (0.49) POLBALDH1A1MEN1KMT2AMAPT
SCHEMBL24403490 0.80 EPHX2 (0.46) POLBALDH1A1THRBL3MBTL1SMN1; SMN2
SCHEMBL6402141 0.80 POLB (0.58) POLBALDH1A1MEN1KMT2AMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7132431-B2 Anti-malarial compounds THE UNIVERSITY OF LIVERPOOL (GB) 2006-11-07 US disclosed
US-20040152729-A1 Anti-malarial compounds THE LIVERPOOL SCHOOL OF TROPICAL MEDICINE (GB) 2004-08-05 US disclosed
EP-1368321-A1 ANTI-MALARIAL COMPOUNDS THE UNIVERSITY OF LIVERPOOL (GB) 2003-12-10 EP disclosed
WO-2002072554-A1 ANTI-MALARIAL COMPOUNDS THE UNIVERSITY OF LIVERPOOL (GB) 2002-09-19 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040152729-A1 Anti-malarial compounds HMBS, MEP1A, QDPR POLB 990/4885ALDH1A1 4003/4885MEN1 3050/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.